EP1037628A4 - Methodes de prevention de la restenose utilisant des tocotrienols - Google Patents

Methodes de prevention de la restenose utilisant des tocotrienols

Info

Publication number
EP1037628A4
EP1037628A4 EP98960259A EP98960259A EP1037628A4 EP 1037628 A4 EP1037628 A4 EP 1037628A4 EP 98960259 A EP98960259 A EP 98960259A EP 98960259 A EP98960259 A EP 98960259A EP 1037628 A4 EP1037628 A4 EP 1037628A4
Authority
EP
European Patent Office
Prior art keywords
tocotrienols
methods
preventing restenosis
restenosis
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98960259A
Other languages
German (de)
English (en)
Other versions
EP1037628A1 (fr
Inventor
Ronald H Lane
Frederick H Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipogenics Inc
Original Assignee
Lipogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenics Inc filed Critical Lipogenics Inc
Publication of EP1037628A1 publication Critical patent/EP1037628A1/fr
Publication of EP1037628A4 publication Critical patent/EP1037628A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Prostheses (AREA)
EP98960259A 1997-11-17 1998-11-17 Methodes de prevention de la restenose utilisant des tocotrienols Withdrawn EP1037628A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97170397A 1997-11-17 1997-11-17
US971703 1997-11-17
PCT/US1998/024606 WO1999025336A1 (fr) 1997-11-17 1998-11-17 Methodes de prevention de la restenose utilisant des tocotrienols

Publications (2)

Publication Number Publication Date
EP1037628A1 EP1037628A1 (fr) 2000-09-27
EP1037628A4 true EP1037628A4 (fr) 2002-08-21

Family

ID=25518699

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98960259A Withdrawn EP1037628A4 (fr) 1997-11-17 1998-11-17 Methodes de prevention de la restenose utilisant des tocotrienols

Country Status (6)

Country Link
EP (1) EP1037628A4 (fr)
JP (1) JP2001522880A (fr)
AU (1) AU746369B2 (fr)
CA (1) CA2310232A1 (fr)
ID (1) ID26335A (fr)
WO (1) WO1999025336A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1270004B1 (fr) * 2000-03-31 2010-06-09 Eisai R&D Management Co., Ltd. Utilisation du gamma-tocotrienol comme diuretique
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DK1521603T3 (da) 2002-07-12 2011-04-18 Cook Inc Coated medicinsk anordning
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US8101199B2 (en) 2003-10-21 2012-01-24 Celonova Biosciences, Inc. Des-methyl-tocopherol therapy for restenosis prevention
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036984A2 (fr) 2004-09-28 2006-04-06 Atrium Medical Corporation Film autonome et procedes de fabrication d'un tel film
EP2471530B1 (fr) 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Produits therapeutiques actifs en reduction-oxydation destines au traitement de maladies mitochondriales et d'autres etats ainsi que la modulation de bio-marqueurs d'energie
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (fr) 2005-10-15 2007-04-26 Atrium Medical Corporation Gels hydrophobes reticules pour revetements bioabsorbables de vecteur de medicament
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057328A2 (fr) 2006-11-06 2008-05-15 Atrium Medical Corporation Dispositif de séparation de tissu avec support renforcé pour mécanismes d'ancrage
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
EP2344142B1 (fr) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Traitement de troubles globaux du développement grâce à des agents thérapeutiques à activité oxydo-réductrice
ES2550634T3 (es) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Uso de nanocristales para un balón de suministro de fármaco
EP2453938B1 (fr) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucléation de ballons d administration de médicament pour fournir une taille et une densité des cristaux améliorées
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
DK2470168T3 (en) 2009-08-26 2018-05-07 Bioelectron Tech Corp PROCEDURES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCAM
WO2012009707A2 (fr) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition et procédés destinés à modifier la vitesse d'hydrolyse de substances vulcanisées à base d'huile
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013028208A1 (fr) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Dispositif médical comprenant un revêtement médicamenteux cristallin
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
RU2613167C2 (ru) * 2012-07-19 2017-03-15 Те Огайо Стейт Юниверсити Способ ослабления нарушения свертывания крови и связанные с этим материалы и методы
WO2017106803A1 (fr) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Dérivés fluoroalkyle, fluoroalcoxy, phénoxy, hétéroaryloxy, alcoxy, et amine 1,4-benzoquinone pour le traitement de troubles du stress oxydatif

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333794A1 (de) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
EP0669132A1 (fr) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Composition pharmaceutique à la vitamine E et à l'acetylsalicylate pour le traitement et la prévention de l'atherosclerosis
US5591772A (en) * 1991-11-22 1997-01-07 Lipogenics, Inc. Tocotrienols and tocotrienol-like compounds and methods for their use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591772A (en) * 1991-11-22 1997-01-07 Lipogenics, Inc. Tocotrienols and tocotrienol-like compounds and methods for their use
DE4333794A1 (de) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
EP0669132A1 (fr) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Composition pharmaceutique à la vitamine E et à l'acetylsalicylate pour le traitement et la prévention de l'atherosclerosis

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
AZZI A ET AL: "MODULATION OF CELL PROLIFERATION BY TOCOPHEROLS AND TOCOTRIENOLS: ROLE IN ARTERIOSCLEROSIS", LIPID SOLUBLE ANTIOXIDANTS: BIOCHEMISTRY AND CLINICAL APPLICATIONS, BIRKHAEUSER VERLAG, BASEL, CH, 1992, pages 123 - 133, XP008004536 *
GELLER M R ET AL: "Palmvitee-induced carotid plaque regression in humans.", STROKE (26, NO. 1, 162, 1995) CODEN: SJCCA7 ISSN: 0039-2499, XP008004540 *
KARPEN C W ET AL: "TOCOTRIENOL-INDUCED INHIBITION OF PLATELET THROMBUS FORMATION AND PLATELET AGGREGATION IN A STENOSEL CORONARY ARTERY CANINE MODEL", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 4, PART 2, no. 90, 14 November 1994 (1994-11-14), pages 1181, XP008004384, ISSN: 0009-7322 *
KOOYENGA D ET AL: "ANTIOXIDANT EFFECTS OF TOCOTRIENOLS IN PATIENTS WITH CAROTID STENOSIS", JOURNAL OF INVESTIGATIVE MEDICINE, AMERICAN FEDERATION FOR CLINICAL RESEARCH,, US, vol. 3, no. 44, 3 May 1996 (1996-05-03), pages 245A, XP008004383, ISSN: 1081-5589 *
PACKER L: "INTERACTIONS AMONG ANTIOXIDANTS IN HEALTH AND DISEASE: VITAMIN E AND ITS REDOX CYCLE", PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY & MEDICINE, ACADEMIC PRESS INC. NEW YORK, US, vol. 2, no. 200, June 1992 (1992-06-01), pages 271 - 276, XP001073940, ISSN: 0037-9727 *
QURESHI A A ET AL: "NOVEL TOCOTRIENOLS OF RICE BRAN MODULATE CARDIOVASCULAR DISEASE RISK PARAMETERS OF HYPERCHOLESTEROLEMIC HUMANS", JOURNAL OF NUTRITIONAL BIOCHEMISTRY, BUTTERWORTH PUBLISHERS, STONEHAM, GB, vol. 8, no. 5, May 1997 (1997-05-01), pages 290 - 298, XP001026694, ISSN: 0955-2863 *
See also references of WO9925336A1 *
TOMEO A C ET AL: "ANTIOXIDANT EFFECTS OF PV IN HYPERLIPIDEMIC SUBJECTS WITH CAROTID ARTERY STENOSIS", CLINICAL RESEARCH, THOROFARE, NJ, US, vol. 2, no. 42, 29 April 1994 (1994-04-29), pages 158A, XP008004385, ISSN: 0009-9279 *
TOMEO ET AL.: "Antioxidant effects of vitamin E and gamma-tocotrienol in hyperlipidemic subjects with carotid artery stenosis - A preliminary report", CLIN. RES., vol. 42, no. 1, - 1994, pages 29a, XP008004386 *

Also Published As

Publication number Publication date
CA2310232A1 (fr) 1999-05-27
AU1590299A (en) 1999-06-07
JP2001522880A (ja) 2001-11-20
EP1037628A1 (fr) 2000-09-27
AU746369B2 (en) 2002-04-18
ID26335A (id) 2000-12-14
WO1999025336A1 (fr) 1999-05-27

Similar Documents

Publication Publication Date Title
EP1037628A4 (fr) Methodes de prevention de la restenose utilisant des tocotrienols
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
GB9702194D0 (en) Sulphonide derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
HUP9802261A3 (en) Protector for cardans
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB2322316B (en) Chuck
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
PL340541A1 (en) Pyridipyrrole derivative
GB9715821D0 (en) Amidino-camptothecin derivatives
ZA9810039B (en) Azoline derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
ZA983116B (en) Arylsecocholadiene derivatives
AU6521198A (en) Agent for preventing restenosis
HU9800889D0 (en) New naphtylpiperazine derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9721196D0 (en) Pipeliner for renovation
GB2314014B (en) Closure-arrangements for loose-covers
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives
EG21550A (en) Catalys for hydroprocessing

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000616

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020709

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030531